Village News - Also serving the communities of De Luz, Rainbow, Camp Pendleton, Pala and Pauma

Participants needed for study on advanced melanoma


Last updated 1/31/2008 at Noon

Melanoma specialists at Moores UCSD Cancer Center are recruiting patients into a large Phase 3 study to evaluate the safety and effectiveness of Allovectin-7, an investigational product for advanced melanoma.

If Allovectin-7 is found to be safe and effective in clinical trials, it may offer patients a new option for fighting melanoma that has progressed to Stage 3 or 4.

Patients eligible for the clinical trial must be at least 18 years old and have confirmed recurrent metastatic melanoma with at least one tumor large enough to inject (about the size of a pea).

Those who have already received chemotherapy for melanoma are not eligible. In addition, patients with lung lesions can be included but those with liver or brain lesions cannot.

To find out whether a person qualifies for the study, visit or contact Moores UCSD Cancer Center Clinical Trials Office at (858) 822-5354.


Reader Comments(0)


Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 09/24/2021 12:32